Literature DB >> 25733132

Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction.

Ivan Jambor1, Marko Pesola1, Pekka Taimen2, Harri Merisaari3,4, Peter J Boström5, Heikki Minn6, Timo Liimatainen7, Hannu J Aronen1,8.   

Abstract

PURPOSE: To investigate relaxation along a fictitious field (RAFF) and continuous wave (cw) T1ρ imaging of prostate cancer (PCa) in the terms of repeatability, PCa detection, and characterization.
METHODS: Thirty-six patients (PSA 11.6 ± 7.6 ng/mL, mean ± standard deviation) with histologically confirmed PCa underwent two repeated 3T MR examinations using surface array coils before prostatectomy. Relaxation along fictitious field, cw T1ρ, and T2 relaxation times (TRAFF, T1ρcw, T2) were measured and averaged over regions of interest placed in PCa, normal peripheral zone (PZ), and normal central gland (CG) positioned using whole-mount prostatectomy sections and anatomical T2-weighted images. Receiver operating characteristic curve analysis with area under the curve (AUC) was calculated to distinguish PCa from PZ/CG and PCa with Gleason score (GS) of 3+3 from GS of 3+4/≥ 3+4.
RESULTS: TRAFF and T1ρcw relaxation times were repeatable with coefficients of repeatability as a percentage of median value in the range of 7.8-23.2%. AUC (mean, 95% confidence interval) in the differentiation of PCa with GS of 3+3 from PCa with CS of ≥ 3+4 were 0.88 (0.72-0.99), 0.69 (0.46-0.90), and 0.68 (0.45-0.88), for TRAFF, T1ρcw, and T2, respectively.
CONCLUSION: In quantitative region of interest based analysis, TRAFF outperformed T1ρcw and T2 in PCa detection and characterization.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Gleason score; prostate cancer; repeatability; rotating frame relaxation

Mesh:

Year:  2015        PMID: 25733132     DOI: 10.1002/mrm.25647

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  7 in total

1.  Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).

Authors:  Ivan Jambor; Anna Kuisma; Esa Kähkönen; Jukka Kemppainen; Harri Merisaari; Olli Eskola; Jarmo Teuho; Ileana Montoya Perez; Marko Pesola; Hannu J Aronen; Peter J Boström; Pekka Taimen; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-16       Impact factor: 9.236

2.  Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization.

Authors:  Jussi Toivonen; Ileana Montoya Perez; Parisa Movahedi; Harri Merisaari; Marko Pesola; Pekka Taimen; Peter J Boström; Jonne Pohjankukka; Aida Kiviniemi; Tapio Pahikkala; Hannu J Aronen; Ivan Jambor
Journal:  PLoS One       Date:  2019-07-08       Impact factor: 3.240

3.  Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

Authors:  Shoshana B Ginsburg; Ahmad Algohary; Shivani Pahwa; Vikas Gulani; Lee Ponsky; Hannu J Aronen; Peter J Boström; Maret Böhm; Anne-Maree Haynes; Phillip Brenner; Warick Delprado; James Thompson; Marley Pulbrock; Pekka Taimen; Robert Villani; Phillip Stricker; Ardeshir R Rastinehad; Ivan Jambor; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2016-12-19       Impact factor: 4.813

4.  Myocardium Assessment by Relaxation along Fictitious Field, Extracellular Volume, Feature Tracking, and Myocardial Strain in Hypertensive Patients with Left Ventricular Hypertrophy.

Authors:  Seyed Amir Mirmojarabian; Eveliina Lammentausta; Esa Liukkonen; Lauri Ahvenjärvi; Juhani Junttila; Miika T Nieminen; Timo Liimatainen
Journal:  Int J Biomed Imaging       Date:  2022-06-23

5.  Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer.

Authors:  Harri Merisaari; Pekka Taimen; Rakesh Shiradkar; Otto Ettala; Marko Pesola; Jani Saunavaara; Peter J Boström; Anant Madabhushi; Hannu J Aronen; Ivan Jambor
Journal:  Magn Reson Med       Date:  2019-11-08       Impact factor: 4.668

6.  T for Radiotherapy Treatment Response Monitoring in Rectal Cancer Patients: A Pilot Study.

Authors:  Ernst S Kooreman; Max Tanaka; Leon C Ter Beek; Femke P Peters; Corrie A M Marijnen; Uulke A van der Heide; Petra J van Houdt
Journal:  J Clin Med       Date:  2022-04-02       Impact factor: 4.241

7.  Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.

Authors:  Shoshana B Ginsburg; Pekka Taimen; Harri Merisaari; Paula Vainio; Peter J Boström; Hannu J Aronen; Ivan Jambor; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2016-06-10       Impact factor: 5.119

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.